Obstructive sleep apnea is a common disorder with increased risk for cardiovascular
morbidity and mortality. The first choice of treatment of obstructive sleep apnea is continuous …

Prospective studies show an association between obstructive sleep apnea and
cardiovascular disease. Continuous positive airway pressure (CPAP) is the treatment of …

The prevalence of obstructive sleep apnea (OSA) is 3% to 7% in the general population [1].
OSA has been found to be associated with cardiovascular disease, leading to high rates of …

Continuous positive airway pressure (CPAP) is the first-line treatment of obstructive sleep
apnea (OSA). Obstructive sleep apnea is a predictor of cardiovascular (CV) events. In this …

Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and
mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

Background Although continuous positive airway pressure (CPAP) has become the first line
of therapy for obstructive sleep apnea (OSA), it remains controversial whether non-sleepy …

Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …